IMRN

Conviction 48HealthcareScan · Thu, Sep 24, 2026

Immuron Ltd (IMRN) closed at $1.19 (+1.71%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 46, RS Rating 32, -49.4% from its 52-week high, +49.7% year to date. Sector: Healthcare · Biotechnology.

IMRN$1.19+1.71%

ResistanceSupportVol 14

Vol MA14 9.32M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Immuron LtdBiotechnologywww.immuron.com.au ↗

Price1.19

Change+1.71%

Gap+0.43%

Rel volume0.00×

Avg volume6.53M

Avg $ vol11.71M

SMA 201.32

SMA 501.20

SMA 2001.01

Price vs 50-0.69%

Price vs 200+18.22%

MA stackmixed

50/200 cross—

Supertrenddown · 1.56

RSI (14)46

MACD hist-0.03

MACD crossbear · 6d

Stoch %K / %D5 / 11

ADX (14)14

+DI / −DI24 / 24

RSI divergence—

MACD divergence—

ATR %10.36%

ADR %8.88%

52w high2.35

52w low0.7000

From 52w high-49.36%

Above 52w low+70.00%

New 52w highNo

SqueezeOff

Bollinger width72.60%

%B0.37

Donchian pos13.98%

Donchian high1.99

Donchian low1.06

AVWAP (52w high)1.67

vs AVWAP high-28.56%

AVWAP (52w low)1.69

vs AVWAP low-29.46%

OBV trendUp

Chaikin MF (20)0.15

Today vs 20d0.00×

Avg vol (14d)9.32M

Avg vol (20d)6.53M

Avg $ vol (20d)11.71M

Market cap9.72M

RS Rating32 / 99

RS 3m (vs SPY)+2.72%

RS 6m (vs SPY)+37.65%

RS line new highNo

Trend template5/8

Technical rank81.3

1 week+0.85%

1 month+4.39%

3 months+7.21%

6 months+54.47%

1 year-37.04%

YTD+49.69%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional0.97%

Ent. value9.72M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out8.17M

Employees7

ListedThu, Dec 13, 2007

Free float7.89M

Float %97.8%

Short interest34.01K

Days to cover2.3d

Short volume30.6%

Squeeze score12 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction48 / 100

Pattern quality—

Tech rank81.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.64

Support1.03

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in IMRN

All disclosures →

No recent disclosed trades by Congress in IMRN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMRN

No recent insider (Form 4) filings in IMRN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IMRN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

IMRN

Recent news

Get daily signals & real-time alerts.